NCT06245746View on ClinicalTrials.gov

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Acute Myeloid LeukemiaNeutropeniaAnemiaThrombocytopeniaInfectionsBleeding
Interventions
BIOLOGICAL

umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo)

UCMSC-Exo will be infused intravenously.

Trial Locations (1)

430000

RECRUITING

Wuhan Union Hospital, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER